BCOR and lymphoma: Furthermore, RNA-seq analysis of Eμ-Myc lymphomas with CRISPR-Cas9-mediated targeted deletion of Bcor showed deletions or insertions proximal to the expected CRISPR-Cas9 trigger sequence in exon 4 that would be expected to cause Bcor loss of function (Supplementary Fig. 11).